Menopause Hormone Therapy (HRT) in Lynchburg, VA

Bioidentical hormones in Lynchburg: what it means

Behind the label "bioidentical hormone replacement therapy" is a plain idea: a hormone whose structure matches the body's own. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. FDA-approved versions of both are sold by prescription at retail pharmacies.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

For women in Lynchburg, a physician licensed in Virginia can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

For its size, Lynchburg is well supplied with OB-GYNs: the NPI registry lists 31, or 39.1 per 100,000 residents, against 17.8 for the US and above Virginia's 18.1. Set against the city's 7,767 women aged 45 to 64, that is one OB-GYN for roughly every 250.

Beyond the city line the count barely changes: 31 OB-GYNs within 10 miles and 32 within 25, for the 256,904 people who live in that radius (12.5 per 100,000). VevaMD is an online option alongside them: a physician licensed in Virginia reviews your intake from Lynchburg without an office visit, and an OB-GYN you already see stays your doctor.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11